ColeBJSchumacherHR. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg. 2005, 13: 37–46.
2.
De Keating-HartETouchaisSKerjeanYArdouinLLe GoffB. Presence of an intracompartmental septum detected by ultrasound is associated with the failure of ultrasound-guided steroid injection in De Quervain's syndrome. J Hand Surg Eur. 2016, 41: 212–9.
3.
EarpBEHanCHFloydWERozentalTDBlazarPE. De Quervain tendinopathy: survivorship and prognostic indicators of recurrence following a single corticosteroid injection. J Hand Surg Am. 2015, 40: 1161–5.
4.
FranchignoniFVercelliSGiordanoASartorioFBraviniEFerrieroG. Minimal clinically important difference of the Disabilities of the Arm, Shoulder and Hand outcome measure (DASH) and its shortened version (QuickDASH). J Orthop Sports Phys Ther. 2014, 44: 30–9.
5.
Gaujoux-VialaCDougadosMGossecL. Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009, 68: 1843–9.
6.
GummessonCAtroshiIEkdahlC. The Disabilities of the Arm, Shoulder and Hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord. 2003, 4: 11.
7.
HudakPLAmadioPCBombardierC. Development of an upper extremity outcome measure: the DASH (Disabilities of the Arm, Shoulder and Hand). The upper extremity collaborative group (UECG). Am J Ind Med. 1996, 29: 602–8.
8.
IlyasAM. Nonsurgical treatment for De Quervain's tenosynovitis. J Hand Surg Am. 2009, 34: 928–9.
9.
IlyasAMAstMSchafferAAThoderJ. De Quervain tenosynovitis of the wrist. J Am Acad Orthop Surg. 2007, 15: 757–64.
10.
JirarattanaphochaiKSaengnipanthkulSVipulakornKJianmongkolSChatuparisutePJungS. Treatment of De Quervain disease with triamcinolone injection with or without nimesulide. A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2004, 86-A: 2700–6.
11.
KumeKAmanoKYamadaSAmanoKKuwabaNOhtaH. In De Quervain's with a separate EPB compartment, ultrasound-guided steroid injection is more effective than a clinical injection technique: a prospective open-label study. J Hand Surg Eur. 2012, 37: 523–7.
12.
Mardani-KiviMKarimi MobarakehMBahramiFHashemi-MotlaghKSaheb-EkhtiariKAkhoondzadehN. Corticosteroid injection with or without thumb spica cast for De Quervain tenosynovitis. J Hand Surg Am. 2014, 39: 37–41.
13.
McDermottJDIlyasAMNazarianLNLeinberryCF. Ultrasound-guided injections for De Quervain’s tenosynovitis. Clin Orthop Relat Res. 2012, 470: 1925–31.
14.
MirzanliCOzturkKEsenyelCZAyanogluSImrenYAliustaogluS. Accuracy of intrasheath injection techniques for De Quervain's disease: a cadaveric study. J Hand Surg Eur. 2012, 37: 155–60.
15.
PagonisTDitsiosKToliPGivissisPChristodoulouA. Improved corticosteroid treatment of recalcitrant De Quervain tenosynovitis with a novel 4-point injection technique. Am J Sports Med. 2011, 39: 398–403.
16.
Peters-VeluthamaningalCvan der WindtDAWintersJCMeyboom-de JongB. Corticosteroid injection for De Quervain's tenosynovitis. Cochrane Database Syst Rev. 2009a, CD005616.
17.
Peters-VeluthamaningalCWintersJCGroenierKHMeyboom-DeJongB. Randomised controlled trial of local corticosteroid injections for De Quervain's tenosynovitis in general practice. BMC Musculoskelet Disord. 2009b, 10: 131.
18.
RohYHNohJHGongHSBaekGH. Effects of metabolic syndrome on the functional outcomes of corticosteroid injection for De Quervain tenosynovitis. J Hand Surg Eur. 2017, 42: 481–6.
19.
SzaboRM. Outcomes assessment in hand surgery: when are they meaningful?J Hand Surg Am. 2001, 26: 993–1002.
20.
TangJB. Re: Level of experience of surgeons in clinical studies. J Hand Surg Eur. 2009, 34: 137–8.
21.
TangJBGiddinsG. Why and how to report surgeons’ levels of expertise. J Hand Surg Eur. 2016, 41: 365–6.
22.
ZingasCFaillaJMVan HolsbeeckM. Injection accuracy and clinical relief of De Quervain's tendinitis. J Hand Surg Am. 1998, 23: 89–96.
